Skip to content


Your cart is empty

Article: Aeroscena® Accepts Cleveland Clinic Invitation

Aeroscena® Accepts Cleveland Clinic Invitation

Aeroscena® is proud to announce it has accepted the Cleveland Clinic Global Cardiovascular Innovation Center’s invitation to their Incubator Program.

The GCIC operates a 50,000 square foot bio-medical incubation facility offering both lab and office space in close proximity to the Cleveland Clinic.  The space will allow Aeroscena® access to world-class clinical researchers, and a wide variety of facility and support services to assist in our continued commitment to the development of innovative new products.

The GCIC incubator provides start-ups with an efficient and customizable working environment to help ensure their success, ranging from flexible lab space, to a shared business center, to onsite IT management.

For more information, visit the GCIC online.

Leave a comment

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

All comments are moderated before being published.

Read more

Do We Need More Common Scents?

By Pete Foley Innovation Consultant + Guest Blogger   Scent often gets a bad rap.  It is frequently presented as an unnecessary chemical load on our environment, and there is a movement away fro...

Read more

NIH Recommends Research into Non-Drug Pain Management

Aeroscena believes strongly in and has been at the forefront of the development of non-drug treatments for chronic pain via the use of clinical aromatherapy since 2010. With promising new researc...

Read more